Skip to main content
Top
Published in: Rheumatology International 7/2012

01-07-2012 | Original Article

Superoxide release in juvenile systemic lupus erythematosus

Authors: Roberto Marini, Antonio Condino-Neto, Simone Appenzeller, André M. Morcillo, Lilian T. L. Costallat

Published in: Rheumatology International | Issue 7/2012

Login to get access

Abstract

The objective of this study was to analyze the un-stimulated and stimulated release of superoxide anion (O2 ) by granulocytes and monocytes in juvenile systemic lupus erythematosus (jSLE). The un-stimulated and phorbol myristate acetate (PMA, 30 nM)-induced O2 by granulocytes and monocytes were determined in six different times of incubation in patients with 23 jSLE and 28 controls. The analysis compared the jSLE group, which was classified into two subgroups by SLEDAI in one inactive subgroup (score <3) (n = 13 patients) and one active subgroup (score ≥3) (n = 10 patients) to the same control group. At time of blood withdrawal, 13 (56.52%) had inactive and 10 (43.47%) patients had active SLE. jSLE patients’ granulocytes and monocytes had always a lower un-stimulated O2 production when compared to controls. Stimulated granulocytes had an increased O2 production at baseline followed by a significant lower production at 60 min in jSLE when compared to controls. Stimulated monocytes had a similar O2 production among patients with jSLE and controls. The results suggest a defect in phagocytic function in jSLE. The significant higher release of O2 in the assays of the stimulated granulocytes, in the initial instances, the so-called respiratory burst, could be attributed to the inflammatory state of phagocytes.
Literature
1.
go back to reference Waszczykowska E, Robak E, Wozniacka A, Narbutt J, Torzecka JD, Sysa-Jedrzejowska A (1999) Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation. Mediators Inflamm 8:93–100PubMedCrossRef Waszczykowska E, Robak E, Wozniacka A, Narbutt J, Torzecka JD, Sysa-Jedrzejowska A (1999) Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation. Mediators Inflamm 8:93–100PubMedCrossRef
2.
go back to reference Antonaccio F, Bassissi P (1994) Free radicals. Chron Dermatol 4:1017–1033 Antonaccio F, Bassissi P (1994) Free radicals. Chron Dermatol 4:1017–1033
3.
go back to reference Buttke TM, Sandstrom PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 25:111–121 Buttke TM, Sandstrom PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 25:111–121
4.
go back to reference Knight JA (1995) Diseases related to oxygen derived free radicals. Ann Clin Lab Sci 25:11–121 Knight JA (1995) Diseases related to oxygen derived free radicals. Ann Clin Lab Sci 25:11–121
5.
go back to reference Aruoma OI (1994) Nutrition and health aspects of free radicals and antioxidants. Food Chem Toxicol 32:671–683PubMedCrossRef Aruoma OI (1994) Nutrition and health aspects of free radicals and antioxidants. Food Chem Toxicol 32:671–683PubMedCrossRef
6.
go back to reference Komatsu H, Tsukimori K, Hata K, Satoh S, Nakano H (2001) The characterization of superoxide production of human neonatal neutrophil. Early Hum Dev 65:11–19PubMedCrossRef Komatsu H, Tsukimori K, Hata K, Satoh S, Nakano H (2001) The characterization of superoxide production of human neonatal neutrophil. Early Hum Dev 65:11–19PubMedCrossRef
7.
go back to reference Perskin MH, Cronstein BN (1992) Age-related changes in neutrophil structure and function. Mech Ageing Dev 64:303–313PubMedCrossRef Perskin MH, Cronstein BN (1992) Age-related changes in neutrophil structure and function. Mech Ageing Dev 64:303–313PubMedCrossRef
8.
go back to reference Poligano A, Tortorella C, Venezia A, Jirillo E, Antonaci S (1994) Age-associated changes of neutrophils responsiveness in a human healthy elderly population. Cytobios 80:145–153 Poligano A, Tortorella C, Venezia A, Jirillo E, Antonaci S (1994) Age-associated changes of neutrophils responsiveness in a human healthy elderly population. Cytobios 80:145–153
9.
go back to reference Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef
10.
go back to reference Liang MH, Corzillius M, Bae SC et al (1999) The American College Nomenclature and case definitions for neuropsychiatric lupus syndrome. Arthritis Rheum 42:599–608CrossRef Liang MH, Corzillius M, Bae SC et al (1999) The American College Nomenclature and case definitions for neuropsychiatric lupus syndrome. Arthritis Rheum 42:599–608CrossRef
11.
go back to reference The Committee on prognosis studies in SLE, Bombardier C, Gladman DD, Urowitz M, Caron D, Chang C (1992) Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630–640PubMedCrossRef The Committee on prognosis studies in SLE, Bombardier C, Gladman DD, Urowitz M, Caron D, Chang C (1992) Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630–640PubMedCrossRef
12.
go back to reference Harris EN, Gharavi AE, Patel SP, Hughes GR (1987) Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 68:215–222PubMed Harris EN, Gharavi AE, Patel SP, Hughes GR (1987) Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 68:215–222PubMed
13.
go back to reference Brandt JT, Triplett DA, Scharer I (1995) Criteria for the diagnosis of lupus anticoagulant: an update. Thromb Haemost 74:1185–1190PubMed Brandt JT, Triplett DA, Scharer I (1995) Criteria for the diagnosis of lupus anticoagulant: an update. Thromb Haemost 74:1185–1190PubMed
14.
go back to reference Boyum A (1968) Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl 97:9–29PubMed Boyum A (1968) Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl 97:9–29PubMed
15.
go back to reference McCord J, Fridovich I (1969) Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049–6055PubMed McCord J, Fridovich I (1969) Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049–6055PubMed
16.
go back to reference Condino-Neto A, Newburger PE (1988) NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system. Arch Biochem Biophys 360:158–164CrossRef Condino-Neto A, Newburger PE (1988) NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system. Arch Biochem Biophys 360:158–164CrossRef
17.
go back to reference Alves CM, Marzocchi-Machado CM, Louzada-Junior P, Azzolini AE, Polizello AC, de Carvalho IF, Lucisano-Valim YM (2007) Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus. Clin Rheumatol 27:701–708PubMedCrossRef Alves CM, Marzocchi-Machado CM, Louzada-Junior P, Azzolini AE, Polizello AC, de Carvalho IF, Lucisano-Valim YM (2007) Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus. Clin Rheumatol 27:701–708PubMedCrossRef
18.
go back to reference Valko M, Leibfritz D, Moncol J et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84PubMedCrossRef Valko M, Leibfritz D, Moncol J et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84PubMedCrossRef
19.
go back to reference Kurien BT, Hensley K, Bachmann M et al (2006) Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med 41:549–556PubMedCrossRef Kurien BT, Hensley K, Bachmann M et al (2006) Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med 41:549–556PubMedCrossRef
20.
21.
go back to reference Ara J, Ali R (1992) Reactive oxygen species modified DNA fragments of varying size are the preferred antigen for human anti-DNA autoantibodies. Immunol Lett 34:195–200PubMedCrossRef Ara J, Ali R (1992) Reactive oxygen species modified DNA fragments of varying size are the preferred antigen for human anti-DNA autoantibodies. Immunol Lett 34:195–200PubMedCrossRef
22.
go back to reference Witt C, Neuhans K, Winsel K, Brenke A, Hiepe F, Volk HD (1991) Bronchoalveolar lavage in patients with systemic lupus erythematosus: characterisation of cell activity by cytofluorometry, chemiluminescence and differential cell count. Z Erkr Atmungsorgane 176:21–29PubMed Witt C, Neuhans K, Winsel K, Brenke A, Hiepe F, Volk HD (1991) Bronchoalveolar lavage in patients with systemic lupus erythematosus: characterisation of cell activity by cytofluorometry, chemiluminescence and differential cell count. Z Erkr Atmungsorgane 176:21–29PubMed
23.
go back to reference Benke PJ, Levcowitz H, Pampe J, Tozman E (1990) Scavengers of free radical oxygen effect in the generation of low molecular weight DNA in stimulated lymphocytes from patients with systemic lupus erythematosus. Metabolism 39:1278–1284PubMedCrossRef Benke PJ, Levcowitz H, Pampe J, Tozman E (1990) Scavengers of free radical oxygen effect in the generation of low molecular weight DNA in stimulated lymphocytes from patients with systemic lupus erythematosus. Metabolism 39:1278–1284PubMedCrossRef
24.
go back to reference Miesel R, Hartung R, Kroeger H (1996) Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic diseases. Inflammation 20:427–438PubMedCrossRef Miesel R, Hartung R, Kroeger H (1996) Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic diseases. Inflammation 20:427–438PubMedCrossRef
25.
go back to reference Gyimesi E, Kavai M, Kiss E, Csipö I, Szücs G, Szegedi G (1993) Triggering of respiratory burst by phagocytosis in monocytes of patients with systemic lupus erythematosus. Clin Exp Immunol 94:140–144PubMedCrossRef Gyimesi E, Kavai M, Kiss E, Csipö I, Szücs G, Szegedi G (1993) Triggering of respiratory burst by phagocytosis in monocytes of patients with systemic lupus erythematosus. Clin Exp Immunol 94:140–144PubMedCrossRef
26.
go back to reference Sambo P, Jannino L, Candela M, Salvi A, Donini M, Dusi S, Luchetti MM, Gabrielli A (1999) Monocytes of patients with systemic sclerosis (scleroderma un-stimulated release in vitro increased amounts of superoxide anion. J Invest Dermatol 112:78–84PubMedCrossRef Sambo P, Jannino L, Candela M, Salvi A, Donini M, Dusi S, Luchetti MM, Gabrielli A (1999) Monocytes of patients with systemic sclerosis (scleroderma un-stimulated release in vitro increased amounts of superoxide anion. J Invest Dermatol 112:78–84PubMedCrossRef
27.
go back to reference Casellas AM, Prat A, Llera A, Manni J, Boveris A, Sarano JF (1991) Increased superoxide production by polymorphonuclear leukocytes in systemic lupus erythematosus. Clin Exp Rheumatol 9:511–514PubMed Casellas AM, Prat A, Llera A, Manni J, Boveris A, Sarano JF (1991) Increased superoxide production by polymorphonuclear leukocytes in systemic lupus erythematosus. Clin Exp Rheumatol 9:511–514PubMed
28.
go back to reference Stewart AG, Dubbin PN, Harris T, Dusting GJ (1990) Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc Natl Acad Sci USA 87:3215–3219PubMedCrossRef Stewart AG, Dubbin PN, Harris T, Dusting GJ (1990) Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc Natl Acad Sci USA 87:3215–3219PubMedCrossRef
29.
go back to reference Moon DG, van der Zee H, Weston LK, Gudewicz PW, Fenton JW 2nd, Kaplan JE (1990) Platelet modulation of neutrophil superoxide anion production. Thromb Haemost 63:91–96PubMed Moon DG, van der Zee H, Weston LK, Gudewicz PW, Fenton JW 2nd, Kaplan JE (1990) Platelet modulation of neutrophil superoxide anion production. Thromb Haemost 63:91–96PubMed
30.
go back to reference Dobrinich R, Spagnuolo PJ (1991) Binding of C-reactive protein to human neutrophils. Inhibition of respiratory burst activity. Arthritis Rheum 34:1031–1038PubMedCrossRef Dobrinich R, Spagnuolo PJ (1991) Binding of C-reactive protein to human neutrophils. Inhibition of respiratory burst activity. Arthritis Rheum 34:1031–1038PubMedCrossRef
31.
go back to reference Marzocchi-Machado CM, Alves CM, Azzolini AE, Polizello AC, Carvalho IF, Lucisano-Valim YM (2002) Fcgamma and complement receptors: expression, role and co-operation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patients. Lupus 11:240–248PubMedCrossRef Marzocchi-Machado CM, Alves CM, Azzolini AE, Polizello AC, Carvalho IF, Lucisano-Valim YM (2002) Fcgamma and complement receptors: expression, role and co-operation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patients. Lupus 11:240–248PubMedCrossRef
Metadata
Title
Superoxide release in juvenile systemic lupus erythematosus
Authors
Roberto Marini
Antonio Condino-Neto
Simone Appenzeller
André M. Morcillo
Lilian T. L. Costallat
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1918-7

Other articles of this Issue 7/2012

Rheumatology International 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.